Serotype III Streptococcus agalactiae from Bovine Milk and Human Neonatal Infections1 by Bohnsack, John F. et al.
Streptococcus agalactiae (group B streptococcus
[GBS]) causes invasive human infections and bovine mas-
titis. This study examined the genetic relationship between
bovine and human serotype III GBS by using molecular
techniques that classify human serotype III GBS into four
distinct phylogenetic lineages. Bovine serotype III GBS
were largely contained in two lineages, which are distinct
from the two major lineages (restriction digest types III-2
and III-3) that infect human neonates. One of the bovine lin-
eages closely resembles the human III-1 lineage, whose
members occasionally cause human neonatal infections.
The bovine strains in the other lineage characteristically
have an initiation factor IF2 gene (infB) H allele and multi-
locus sequence types that are not found in human GBS
strains. Evidence suggests that this “H allele” lineage is
related to the human III-3 lineage. These results support
the assertion that human and bovine GBS are largely unre-
lated and provide further insight into the genetic relation
between human and bovine GBS. 
S
treptococcus agalactiae (group B streptococcus
[GBS]) is the major etiologic agent of invasive neona-
tal infections in humans in industrialized countries, caus-
ing sepsis, pneumonia, meningitis, osteomyelitis, and soft
tissue infections (1). GBS has also been increasingly rec-
ognized as an important pathogen in immunocompromised
and elderly persons (2,3). GBS emerged as an important
cause of neonatal infections in the 1960s; before this time,
it was mainly recognized as a cause of bovine mastitis (4).
Most data suggest that GBS strains that infect humans are
distinct from strains isolated from bovine sources, since
bovine strains frequently cannot be typed with antisera to
determine capsular polysaccharide serotype, often express
protein antigens not found on human isolates, and tend to
have different biochemical properties (5–8). The possibili-
ty remains, however, that subgroups of GBS infect both
humans and cows. If so, these two closely associated hosts
could act as reservoirs for each other and sites for the
emergence of novel pathogens.
A number of molecular methods, including multilocus
enzyme electrophoresis, pulsed-field gel electrophoresis
(PFGE) of restriction enzyme digest products of genomic
DNA, randomly amplified polymorphic DNA (RAPD)
analysis, and multilocus sequence typing (MLST), have
been used to demonstrate that the population of GBS that
infects humans is highly clonal and limited to a relatively
small number of phylogenetic lineages (9–13). Martinez
and colleagues reported in 2000 that a large sample of
GBS isolated from cows in Quebec Province in Canada
could be classified into five major RAPD groups, which
indicates that this sample of bovine GBS also comprised a
limited number of lineages (7). 
The Quebec sample is particularly useful for further
investigating the relationship between bovine and human
GBS because most typeable bovine isolates in the sample
were serotype III. Serotype III GBS strains account for a
substantial proportion of early-onset neonatal human GBS
infections and almost all late-onset neonatal infections (2).
Four distinct phylogenetic lineages of human serotype III
GBS have been identified by PFGE of restriction digest
patterns and designated restriction digest patterns type III-
1, III-2, III-3, and III-4 (11). Human GBS strains can also
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tinct set of molecular markers, which include analysis of
nucleotide substitutions in the centrally conserved region
of the translation infB, the presence or absence of the
inserted sequences GBSi1 and IS1548 in three chromoso-
mal loci, and MLST (9,11). 
RAPD analysis of human GBS isolates collected with
the Quebec bovine isolates suggested that the serotype III
bovine strains and human GBS strains were largely unre-
lated, although a definite conclusion was hindered by the
small number of human isolates in the study. The obstacle
presented by the small human sample size can now be cir-
cumvented by the use of the molecular markers described
above that identify human phylogenetic lineages of GBS,
but which have not yet been applied to the study of GBS
from nonhuman sources. We reexamined the Quebec sam-
ple with these molecular markers to better understand the
genetic relationship between bovine serotype III GBS and
human serotype III GBS.
Methods
Bacterial Isolates 
The serotype III GBS were isolated from bovine milk
or from vaginal and rectal swab specimens from asympto-
matic pregnant women in Quebec Province, Canada, dur-
ing 1996 and 1997, as previously described (7). RAPD
analysis of the 224 bovine GBS isolates had assigned 210
of the isolates to four RAPD groups (I–IV); the remaining
14 isolates were ungrouped (Figure). Atotal of 70 of the 82
original serotype III GBS strains were recovered for this
study. The remaining GBS in this collection were not
serotype III or were nontypeable. Bovine isolates were
studied from all RAPD groups except RAPD group I,
which contained a single bovine serotype III GBS isolate
that could not be recovered. Genomic DNA was extracted
with the Qiagen DNeasy Tissue Kit (Qiagen, Valencia,
CA) from individual colonies grown overnight in broth. 
Molecular Analyses
The central portion of infB was amplified from bacteri-
al DNAby polymerase chain reaction (PCR) with oligonu-
cleotide primers, as described by Hedegaard et al. (14).
Each amplicon was purified and sequenced.
The presence or absence of the inserted sequences
GBSi1 and IS1548 in the respective chromosomal loci was
determined by using PCR of bacterial DNA with primer
pairs flanking each of three sites, as previously described
(11). In human serotype III GBS, the first locus is an inter-
nal region of hylB, the gene encoding hyaluronidase,
which is either interrupted by IS1548 or is intact. The sec-
ond locus is the region between scpB and lmb, the genes
encoding streptococcal C5a-ase and a laminin-binding
protein, which either contains GBSi1, IS1548, or no insert.
The third locus lies between ftsY and sag0728, two open
reading frames (ORFs) with gene products of unknown
function, which contains GBSi1 or no insert. The latter
locus is either referred to as the AW-10 locus (as we refer
to it) or the Y locus, according to Luan et al. (15).
MLST was carried out on 46 selected strains as previ-
ously described, and a sequence type was assigned to each
strain (9). The sequences of the alleles that make up the
novel MLST sequence types described in this manuscript
can be found at http://sagalactiae.mlst.net (9). DNA dot
blots were performed by using a 96-chamber vacuum man-
ifold and [32P]-dCTP labeled probes as previously
described (16). 
The complete sequences of the infB gene H allele and
the novel IS1563-like insertion sequence described in this
article are available in the GenBank database under acces-
sion nos. AY429663 and AY437915, respectively. 
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Figure. Simplified dendrograms illustrating the genetic relationship between human and bovine group B streptococcus. A) Dendrogram
of Quebec sample derived by randomly amplified polymorphic DNA (RAPD) analysis; adapted from (7). All RAPD groups contain bovine
serotype III GBS, but those marked by an asterisk also contain human isolates (see Table 2). B) Dendrogram of human restriction digest
pattern types (RDP) of serotype III GBS derived by analysis of RDP of genomic DNA created by digestion with restriction enzyme
Sse83871; adapted from (11). Results
Analysis of infB Alleles in Bovine GBS 
All human serotype III GBS have either the A or C
allele of the gene encoding translation-initiation factor IF2
(infB allele, Table 1). Twenty-five of the 62 Quebec
bovine isolates carried the A allele, and 2 carried the C
allele, which raises the possibility that these 27 bovine
GBS could be closely related to human GBS (Table 2). No
strains bearing the B allele were identified, and only one
strain carried the D allele. Serotype III GBS that bear the
D allele are unlikely to be isolated from humans because
all human GBS strains bearing the D allele have thus far
been serotype Ia. The remaining 34 strains contained a
previously unidentified infB allele, which we have desig-
nated the H allele. The infB H allele differs from other
previously identified infB alleles (designated A–G) by
two, three, or five nucleotide substitutions within the cen-
tral conserved portion of the infB gene and most closely
resembles the infB A allele (11,14). All 34 of the strains
bearing the H alleles are bovine in origin (Table 2). The
infB H allele has not been previously encountered in
approximately 700 GBS isolates isolated from human
sources studied in our laboratory, including over 150
serotype III strains (unpub. data; [11]). These observa-
tions suggest that GBS bearing the infB H allele rarely, if
ever, colonize or infect humans.
Relationship between infB Allele and RAPD Group 
The possibility that the A or C allele bovine strains
could be related to human GBS was investigated by exam-
ining the distribution of the bovine A or C allele isolates
among the groups previously determined by RAPD analy-
sis (Figure) (7). Of the 25 bovine Aallele isolates, 19 were
found in RAPD group IV-A, and 2 were found in RAPD
group IV-C, which suggests that at least some of the
bovine A allele isolates could be genetically related to
human GBS since human Aallele isolates are also found in
these two RAPD clusters (Table 2, Figure). The two
bovine C allele isolates are in RAPD group IV-C clustered
with two human C allele isolates and thus appear closely
related to human C allele isolates based on RAPD analy-
sis. As expected, neither the single bovine D allele isolate
nor the 34 bovine H allele isolates cluster with human iso-
lates by RAPD analysis (Table 2).
Identification of Bovine Serotype III GBS 
Related to Type III-1 GBS 
The bovine A and C allele isolates were further exam-
ined by using techniques that distinguish the four known
human serotype III GBS lineages. These techniques
include determining the presence or absence of inserted
sequences in three previously identified loci and determin-
ing the strains’ sequence types by MLST (Table 1).
Twenty-three of the 25 A allele bovine isolates appear
closely related to human restriction digest pattern type III-
1 strains because the isolates lack inserted sequences at
any of the three loci examined and had a sequence type
(ST) identical to those of previously studied III-1 strains
(ST-23) or that was different by only one allele (ST-90, ST-
92, or ST-94) (Table 3). Thus, a substantial proportion of
the serotype III bovine GBS in this sample appear to come
from a lineage that is associated with invasive neonatal
disease, albeit rarely (9,17,18). Bovine III-1 strains appear
to be genetically heterogeneous since they are found in
RAPD groups III, IV-A, and IV-C, but no human III-1
strains were found in this sample; thus, the bovine III-1
strains most closely related to human III-1 strains could
not be identified in this sample. Nineteen of the III-1
bovine isolates appear to lack the scpb-lmb locus because
PCR with primers flanking the intergenic locus of lmb and
scpB did not produce an amplicon. 
Seven of the A allele strains appear to be restriction
digest pattern type III-2 strains on the basis of an analysis
of inserted sequences and MLST (Table 3). Only one of
these seven isolates, NI-96-2836, is of bovine origin, how-
ever, and is found in RAPD group III, whereas the six
human A allele isolates are found in RAPD groups IV-A
and IV-C. These data suggest that the bovine NI-96-2836
strain is genetically divergent from human III-2 strains,
despite sharing the same infB allele, inserted sequences,
and ST with human III-2 strains. These data also suggest
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Table 1. Characteristics of human serotype III GBS lineages
a  
    Inserted sequence sites
b
   
RDP type
c  infB allele
d  AW-10  hylB  scpb-lmb  ST
e 
III-1  A  No insert  No insert  No insert  23, 25 
III-2  A  No insert  IS1548  IS1548  19, 21 
III-3  C  GBSi1  No insert  GBSi1  17, 29 
III-4  A  No insert  No insert  GBSi1  1 
aGBS, group B streptococcus.  
bThe presence of inserted sequences is determined at the three chromosomal locations (see Methods).  
cRDP type refers to phylogenetic lineages originally defined by analysis of restriction digest patterns of chromosomal DNA.  
dinfB is the highly conserved gene encoding initiation-translation factor IF2.  
eST refers to the isolates’ sequence type, based on the alleles of seven housekeeping genes identified by multilocus sequence typing.  
 that restriction digest pattern type III-2 strains, a major
cause of human neonatal infections, are rarely, if ever, iso-
lated from bovine milk. 
One of the two remaining A allele strains, SH-96-4807,
appears indistinguishable from III-3 strains on the basis of
MLST because it has ST-17, which is characteristic of III-
3 strains. Unlike III-3 strains, however, SH-96-4807 has no
inserted sequences in any of the three sites and contains an
infB A allele instead of the C allele typical of III-3 strains.
The remaining A allele isolate, SH-96-3696, appears to be
most closely related to H allele strains, on the basis of its
RAPD group, inserted sequences, and ST. No bovine iso-
late related to restriction digest pattern type III-4 was
found in this sample.
The four C allele isolates have the typical inserted
sequences and ST (ST-17) found in restriction digest pat-
tern type III-3 strains, with the exception of human isolate
1004A, which has a truncated form of IS1548 in the scpb-
lmb intergenic region (Table 4). These strains, which clus-
ter together in RAPD Group IV-C, were isolated from both
human and bovine sources. These data indicate that strains
from the restriction digest pattern type III-3 lineage infect
both humans and bovine udders but that bovine III-3 strains
are rare. The only D allele strain has ST-93, an ST which
differs by at least three alleles from all the STs previously
described for human GBS, which again indicates that D
allele serotype III GBS rarely or never colonize humans.
Analysis of H Allele Isolates 
Ten H allele isolates were selected to represent strains
from RAPD Group II, Group III, and the ungrouped iso-
lates and analyzed in the same fashion. As shown in Table
5, all of the isolates studied have large inserts in the AW-
10 site. The 1,700-bp inserts would be the correct size for
the GBSi1 insert found in III-3 strains, and sequencing
demonstrated an intact copy of GBSi1 in a 1,700-bp ampli-
con from one of the strains. A 3,000-bp insert from one
strain was amplified and sequenced and found to comprise
GBSi1, interrupted by an IS3-like insertion sequence iden-
tical to sequences found in both the genome M1 strain of
S. pyogenes and the genome serotype V strain of S. agalac-
tiae (19,20). 
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Table 2. Distribution of infB alleles in serotype III GBS from different RAPD groups
a 
      infB allele 
RAPD group
b  Species of origin   Isolates studied   A  B  C  D  H 
II  Bovine  31  1  0  0  0  30 
III  Bovine  4  3  0  0  1  0 
Bovine  19  19  0  0  0  0  IV-A 
Human  1  1  0  0  0  0 
IV-B  Bovine  2  0  0  0  0  2 
Bovine  4  2  0  2  0  0  IV-C 
Human  7  5  0  2  0  0 
Ungrouped  Bovine  2  0  0  0  0  2 
  Total  70  31  0  4  1  34 
aGBS, group B streptococcus.  
bRAPD group identified by randomly amplified polymorphic DNA analysis.  
Table 3. Inserted sequences and sequence type (ST) of bovine strains containing the infB A allele
a  
      Inserted sequence site    
RAPD group  Isolate  Origin  AW-10  hylB  scpb-lmb  ST  RDP type 
II  SH-96-3696  Bovine  3,400
b  None  None  67  Unknown
c 
III  NI-96-2836  Bovine  None  IS1548  IS1548  19  III-2-like 
  SH-96-4807  Bovine  None  None  None  17  III-3-like 
  RF-96-2997  Bovine  None  None  None  94  III-1 
IV-A  1003A  Human  None  IS1548  IS1548  19  III-2 
  AL-97-0498  
SH-96-3417 
Bovine  None  None  None  23  III-1 
  All 17 others  Bovine  None  None  No product
d  23,90,92  III-1-like 
IV-C  NI-96-3213  Bovine  None  None  No product
d  23  III-1-like 
  ASS-96-666  Bovine  None  None  No product
d  23  III-1-like 
  1007B  Human  None  IS1548  IS1548/IS1381
e  86  III-2 
  1009A, 15888  Human  None  IS1548  IS1548  19  III-2 
  13228, 1009B  Human  None  IS1548 (truncated)
f  IS1548  19  III-2 
aRAPD, randomly amplified polymorphic DNA; RDP, restriction digest pattern.  
bA 3,400-bp insert is also found in other strains from randomly amplified polymorphic DNA (RAPD) group II (see text and Table 5).  
cThis strain appears to be related to the H allele strains described in Table 5.   
dNo polymerase chain reaction product was produced from these strains in multiple attempts.  
eIn this strain, the insertion sequence IS 1381 is upstream from IS 1548 in the scpb-lmb locus.  
fS1548 in the hylB locus is missing 657 bp from the 3′ end of its open reading frame in this strain.   A 3,400-bp insert was sequenced and found to consist
of an inserted sequence that has identical direct and invert-
ed repeat sequences to the insertion sequence IS1563, but
it has a predicted amino acid sequence that is 75% identi-
cal to that of IS1563. This IS1563-like insertion sequence
is located upstream of GBSi1 exactly as IS1563 is found
upstream of GBSi1 in this locus in restriction digest pat-
tern type II-2 strains (11). 
The AW-10, hylB, and scpb-lmb loci were studied in the
remaining H allele strains not shown in Table 5. No insert-
ed sequences were found in the AW-10 site in seven iso-
lates, while the remaining strains have either the 1,700-bp,
3,000-bp, or 3,400-bp inserts at AW-10. No inserted
sequences were found in the hylB and scpb-lmb sites in any
of the H allele strains. Two of the H allele strains, both of
which are in RAPD group IV-B, appear to lack the scpb-
lmb locus.
MLST shows that 8 of these 10 H allele isolates are ST-
61. ST-61 isolates are found in RAPD groups II, IV, and in
ungrouped isolates, which indicates genetic divergence
among H allele strains that is detected by RAPD but not by
MLST. ST-61 differs from ST-67 by one allele, which con-
firms that SH-96-3696, the A allele strain found in RAPD
II that has ST-67, is in the same clonal complex as the H
allele serotype III strains. SH-96-3696 also has a 3,400-bp
insert at AW-10, and no insert at the other two sites, which
provides further evidence that this isolate is related to H
allele strains. The other two STs found in the H allele
strains, ST-91 and ST-105, differ from ST-61 by two alle-
les. Thus, the H allele strains are clonally related. 
III-3–specific Sequence Tags in H Allele 
Serotype III GBS
ST-61, the most common ST of the H allele strains, dif-
fers by two alleles from ST-17, the most common ST of
III-3 strains. This two-allele difference in ST and the
observation that isolates from these two lineages both have
GBSi1 in the AW-10 site led us to search for other evi-
dence that the two lineages are related. 
We previously described 10 short sequence tags that are
found in all III-3 strains but not in III-1 or III-2 strains
(16). We therefore performed dot-blot hybridization with
eight of these probes on a selection of A, H, and C allele
strains from this sample to determine the distribution of the
III-3–specific sequences among these various lineages. As
expected, all of the III-3–specific probes hybridized with
every C allele strain tested, whereas the III-3 probes
hybridized rarely or never with the Aallele strains. In con-
trast, seven of the eight III-3 probes hybridized with
almost all the H allele strains (Table 6). 
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Table 4. Analysis of inserted sequences of strains containing the infB C allele
a 
      Inserted sequence site      
RAPD  Isolate  Origin  AW-10  hylB  scpb-lmb  ST  RDP type 
IV-C  SF 96-5547  Bovine  GBSi1  700  GBSi1  17  III-3 
  1004A  Human  GBSi1  700  IS1548
b  17  III-3 
  1000B  Human  GBSi1  700  GBSi1  17  III-3 
  SF-96-4054  Bovine  GBSi1  700  GBSi1  17  III-3 
aRAPD, randomly amplified polymorphic DNA; ST, sequence type; RDP, restriction digest pattern.  
bAn insert highly homologous to IS 1548 but lacking bp 603–1,301 was found in th is strain. IS1548 has not previously been found in this locus in III-3 
strains. 
 
Table 5. Inserted sequences and sequence types of infB H allele strains
a 
    Size of PCR poroduct from inserted sequence sites (bp)    
RAPD  Isolate  AW-10  hylB  scpb-lmb  ST 
II  RF-96-2834  3,000
b  700
c  650
d  61 
  ASS-97-0701  3,000  700  650  61 
  AL-96-1653  1,700
e  700  650  61 
  SF-96-6312  3,400
f  700  650  61
g 
  SF-96-4396  1,700  700  650  91 
  NI-96-2521  3,000  700  650  105 
IV-B  ASS-96-659  3,000  700  No product  61
g 
  SH-96-5461  1,700  700  No product  61 
Ungrouped  AL-96-2049  3,000  700  650  61 
  NI-96-3329  3,000  700  650  61 
aRAPD, randomly amplified polymorphic DNA; ST, sequence type.  
bA 3,000-bp amplicon was sequenced and found to contain an IS3-like insertion sequence interrupting GBSi1.  
cA 700-bp product from the  hylB site indicates that there is no inserted sequence in the si te.  
dA 650-bp product from the  scpb-lmb site indicates that there is no inserted sequence in the site.  
eA 1,700-bp product was amplified and found to contain an intact copy of GBSi1.  
fA 3,400-bp amplicon was sequenced and found to contain GBSi1 and an IS1563-like insertion sequence .   
gThe glcK (glucose kinase) gene in these two strains contains a mobile genetic element in the portion of glcK used to determine the ST of GBS strains. 
These two strains were found to be sequence type 61 (ST-61) after the inserted sequence was removed. The identical inserted sequence in the glcK  
gene has been found in other ST-61 bovine strains and is described elsewhere (21).  Discussion
A key finding of this investigation is that the serotype
III GBS strains isolated from bovine milk in this sample
are largely genetically distinct from the serotype III GBS
strains that commonly infect humans. The two most com-
mon lineages of serotype III GBS that colonize women and
infect infants in the United States and Japan are restriction
digest pattern types III-2 and III-3, whereas III-1 and III-4
strains are rarely isolated from the genitourinary tract of
women and are rarely associated with invasive disease
(11,16). 
Only one bovine strain that resembled RDP type III-2
GBS was identified in the 67 isolates, and RAPD analysis
indicates that this isolate is distinct from the 7 human III-
2 strains in the sample. Thus, III-2 strains that infect
humans are unlikely to infect bovine udders. Only two
bovine strains were identified that had the genotypic char-
acteristics of restriction digest pattern type III-3 strains.
These two strains appear closely related to two human III-
3 isolates by RAPD analysis, which makes it likely that
III-3 strains can infect bovine udders, but they appear to do
so infrequently. 
We also found that the vast majority of bovine serotype
III GBS in this sample belong to one of two major phylo-
genetic lineages. A separate study of bovine GBS isolates
collected in the United Kingdom used MLST to identify
two clonal complexes that are similar, if not identical, to
the two lineages identified here; this finding suggests that
two clones of GBS may predominate among bovine masti-
tis caused by GBS in North America and England (21). 
The data presented here show that the first bovine line-
age is closely related to restriction digest pattern type III-1
GBS (Table 7). The lack of human III-1 strains in this sam-
ple makes it difficult to use the RAPD analysis to deter-
mine how closely these III-1–like bovine strains resemble
human III-1 strains. That no III-1 human isolates were
found in this small sample is not surprising because human
III-1 isolates rarely colonize the female genitourinary tract
(although they occasionally cause neonatal infections)
(9,17,18). Most III-1 bovine isolates in the sample studied
here appear to lack the scpb-lmb locus, a finding consistent
with that reported by Francken et al., who showed that
absence of a putative composite transposon that contains
the scpB and lmb genes is a feature of bovine GBS (22).
Possibly only a few of the III-1 bovine GBS are capable of
infecting both humans and cows, since all human GBS
appear to have the scpb-lmb locus. 
The other major bovine serotype III GBS lineage in
this sample is composed of strains that possess an infB H
allele, with the exception of a single Aallele strain that, on
the basis of RAPD and MLST, appears closely related to
the H allele strains. The H allele strains have STs that dif-
fer from each other by no more than two alleles, which
indicates that these strains are likely to have a recent com-
mon ancestor. 
We believe that strains in this lineage are unlikely to
colonize or infect humans since we have not identified an
infB H allele strain in >160 human serotype III GBS iso-
lates, and since the STs of the bacteria in this lineage were
not found in a large sample of human GBS obtained from
diverse geographic areas (9). However, the major ST (ST-
61) found in this lineage differs from the major ST of III-
3 strains by only two alleles, which suggests that strains
from this group may share a relatively recent common
ancestor. H allele strains were found to contain previously
identified III-3–specific sequence tags, which supports this
hypothesis. 
The identification of two III-3 strains of bovine origin
and a third bovine strain (SH-96-4807) that is genetically
distinct from III-3 strains but with the ST typical of III-3
strains (ST-17) supports the concept that III-3 strains share
a recent common ancestor with H allele strains and retain
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Table 6. Distribution of III-3–specific sequence tags  
infB allele
a  III-3–specific 
sequence  H  A  C 
DY-1  10/10
  0/10  3/3 
DY-3  2/10  1/10  3/3 
DY-11  7/10  0/10  3/3 
AA 3.8  10/10  2/10  3/3 
AA 3.14  10/10  0/10  3/3 
AA 3.16  9/10  1/10  3/3 
AA 4.1  10/10  2/10  3/3 
AA 4.13  10/10  0/10  3/3 
aNumber of strains with sequence tag by DNA hybridization/number of 
strains tested.  
 
Table 7. Similarities and differences between the two major bovine lineages and related human lineages  
Bovine lineage  Human lineage  Similarities  Differences 
III-1  III-1  Same infB allele (A) 
No inserted sequences in AW -10, hylb or scpb-
lmb sites 
Sequence types (STs) the same or differ by  <1 
allele by multilocus sequence typing (MLST)  
Many bovine III -1 strains lack  scpb-lmb 
H allele  III-3  GBSi1 inserted in AW -10 site  
No inserted sequence in  hylb 
STs differ by only two alleles by MLST  
III-3 specific sequence tags in genome  
Different infB allele (H vs C)   
BSi1 not found in  scpb-lmb 
Additional inserted sequences or none in AW -
10 site with GBSi1   
Some bovine H allele strains lack  scp-lmb some genetic traits necessary for bovine udder coloniza-
tion. No bovine III-2 strains were identified, but a single
bovine strain (NI-96-2836) appears to be related to strains
in the III-2 lineage by all molecular markers (although
RAPD analysis found it to be clearly distinct from human
III-2 isolates). These III-3–like and III-2–like bovine
strains are both in RAPD group III (Table 3) and thus
appear by RAPD analysis to be more related to each other
than to other major bovine lineages or to human isolates.
RAPD analysis also suggests that human III-3 strains are
more related to human III-2 strains than to the H allele
strains, despite the observation that MLST puts human III-
3 strains at a greater phylogenetic distance from III-2
strains than from the H allele strains. 
The clustering together of human III-2 and III-3 isolates
by RAPD analysis, despite their clear distinction by
MLST, leads us to hypothesize that common genetic deter-
minants that account for host tropism (human versus
bovine) have been acquired by both the III-2 and III-3 lin-
eages and strongly influence the clustering of isolates, as
shown by RAPD analysis. If so, the two bovine isolates
that closely resemble III-3 and III-2 strains by MLST, but
which resemble each other more closely by RAPD analy-
sis, may represent intermediate genotypes between GBS
lineages that have a more clear-cut tropism for either
humans or bovines. The exact relationship between these
human and bovine lineages, and genes important for host
tropism, could be clarified by comparative genomics. Such
studies, along with further studies of bovine GBS lineages
of other serotypes, could also provide insight into the exact
relationship between human and bovine strains and help
determine whether these hosts act as reservoirs for each
other’s pathogenetic lineages and for the emergence of
new pathogenic clones. 
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